HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymosin fraction 5 does not influence urinary tract carcinogenesis by phenacetin and N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.

Abstract
The effect of thymosin fraction 5 (TF5) on the promotion and progression phases of urinary tract carcinogenesis induced by consecutive administration of phenacetin and N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) in NON/Shi mice was investigated. The study was carried out twice with a minor modification to the protocol in the second experiment. Fifty-seven male NON/Shi mice in experiment 1 and 100 mice in experiment 2 were each divided into four groups. Phenacetin was administered for 8 weeks in experiment 1 and 12 weeks in experiment 2, and subsequently BBN was given for 6 weeks in both cases, for total observation periods of 30 and 34 weeks, respectively. Sixty micrograms of TF5 per mouse was inoculated subcutaneously twice a week during (group 2) or after (group 3) BBN exposure, or both periods (group 4). Group 1 served as a control group without TF5 treatment. Histopathological examination revealed no effects on either induction of urinary tract carcinomas or distant metastasis from renal pelvic carcinomas in either experiment.
AuthorsT Murai, H Iwata, S Mori, F Hato, S Kimura, Y Kinoshita, S Wada, T Kishimoto, S Makino, T Oohara
JournalOncology research (Oncol Res) Vol. 7 Issue 3-4 Pg. 139-44 ( 1995) ISSN: 0965-0407 [Print] United States
PMID8555647 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Phytohemagglutinins
  • thymosin fraction 5
  • Concanavalin A
  • Butylhydroxybutylnitrosamine
  • Thymosin
  • Phenacetin
Topics
  • Animals
  • Butylhydroxybutylnitrosamine (toxicity)
  • Carcinogens (toxicity)
  • Cocarcinogenesis
  • Concanavalin A (pharmacology)
  • Drug Interactions
  • Lymphocytes (drug effects, immunology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Phenacetin (toxicity)
  • Phytohemagglutinins (pharmacology)
  • Spleen (cytology, drug effects, immunology)
  • Thymosin (analogs & derivatives, toxicity)
  • Urologic Neoplasms (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: